Wilson Sonsini Goodrich & Rosati represented WuXi AppTec and WuXi HK in the offering. WuXi AppTec (HongKong) Limited (WuXi HK), WuXi AppTec Co., Ltd (WuXi AppTec),...
WuXi AppTec’s $500 Million Zero Coupon Convertible Notes OfferingWuXi AppTec’s $500 Million Zero Coupon Convertible Notes Offering
Takeda’s $75 Million Investment in Ascentage Pharma
Wilson Sonsini Goodrich & Rosati acted as the U.S. and Hong Kong counsel to Ascentage Pharma in the transaction. Ascentage Pharma Group International (Ascentage Pharma) (6855.HK)...
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd.’s Listing on the Main Board of the Hong Kong Stock Exchange
Herbert Smith Freehills has advised China International Capital Corporation as the sole sponsor on the listing of LEPU ScienTech Medical Technology while Wilson Sonsini Goodrich &...
Ascentage Pharma’s Strategic Collaboration with Innovent Biologics
Wilson Sonsini Goodrich & Rosati advised Ascentage Pharma on the deal. Ascentage Pharma and Innovent Biologics announced a multifaceted strategic collaboration. This collaboration includes the joint...
Ascentage Pharma’s Strategic Collaboration with Innovent Biologics
Wilson Sonsini Goodrich & Rosati advised Ascentage Pharma on the deal. Ascentage Pharma and Innovent Biologics announced a multifaceted strategic collaboration. This collaboration includes the joint...